MedPath

Flow versus Pressure Controlled Ventilation in patients with moderate to severe Acute Respiratory Distress Syndrome

Recruiting
Conditions
moderate to severe Acute Respiratory Distress Syndrome and pulmonary inflammatory disease
10024967
Registration Number
NL-OMON53828
Lead Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
28
Inclusion Criteria

In order to be eligible to participate in this study, a subject must meet all
of the following criteria:

- 18 years or older;
- Provided written informed consent;
- Undergoing controlled mechanical ventilation via an endotracheal tube;
- Meeting all criteria of the Berlin definition of ARDS:
o Hypoxic respiratory failure within 1 week of a known clinical insult or new
or worsening respiratory symptoms
o Bilateral opacities on X-ray or CT-scan not fully explained by effusions,
lobar/lung collapse (atelectasis), or nodules
o Respiratory failure not fully explained by cardiac failure or fluid overload.
o Oxygenation: moderate ARDS P/F ratio between 101-200 mmHg, severe ARDS PF
ratio <= 100mmHg, both with PEEP >= 5 cmH2O.
- Development of ARDS <= 72 uur
- Intubated

Exclusion Criteria

- Severe sputum stasis or production requiring frequent bronchial suctioning
(more than 5 times per nurse shift) - Untreated pneumothorax (i.e. no pleural
drainage) - Hemodynamic instability defined as a mean arterial pressure below
60mmHg not responding to fluids and/or vasopressors or a noradrenalin dose >
0.5mcrg/kg/min - High (>15 mmHg) or instable (an increase in sedation or
osmotherapy is required) intracranial pressure - An inner tube diameter of 6mm
or less - Anticipating withdrawal of life support and/or shift to palliation as
the goal of care - Inability to perform adequate electrical impedance
tomography (EIT) measurements - Contra-indications for nasogastric tube or
inability to perform adequate transpulmonary pressure measurements

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath